Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis in Pediatric Subjects

Clinical trial NCT05223478 · COMPLETED

Trial details

NCT number: NCT05223478
Sponsor: Ocuphire Pharma, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Mydriasis Dilation

Start date: 2021-12-17
Primary completion: 2022-04-18
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.